- Open Access
Association of knee pain and different definitions of knee osteoarthritis with health-related quality of life: a population-based cohort study in southern Sweden
© The Author(s). 2016
- Received: 9 February 2016
- Accepted: 23 August 2016
- Published: 26 August 2016
While the impact of knee pain and knee osteoarthritis (OA) on health-related quality of life (HRQoL) has been investigated in the literature, there is a lack of knowledge on the impact of different definitions of OA on HRQoL. The main aim of this study was to measure and compare the impact of knee OA and its different definitions on HRQoL in the general population.
A random sample of 1300 participants from Malmö, Sweden with pain in one or both knees in the past 12 months with duration ≥4 weeks and 650 participants without were invited to clinical and radiographic knee examination. A total of 1527 individuals with a mean (SD) age 69.4 (7.2) participated and responded to both generic (EQ-5D-3L) and disease-specific (the Knee injury and Osteoarthritis Outcome Score) questionnaires. Knee pain was defined as pain during the last month during most of the days. Knee OA was defined radiographically (equivalent to Kellgren and Lawrence grade ≥2) and clinically according to the American College of Rheumatology (ACR) criteria.
Of participants with either knee pain or knee OA or both, 7 % reported no problem for the EQ-5D-3L attributes. The corresponding proportion among references (neither knee pain nor OA) was 42 %. The participants with knee pain and OA had all HRQoL measures lower compared to those with knee pain but no OA. The ACR clinical definition of knee OA was associated with lower HRQoL than the definition based on radiographic knee OA (adjusted difference −0.08 in UK EQ-5D-3L index score).
Applying different definitions of knee OA result in different levels of HRQoL and this is mainly explained by the knee pain experience. These differences may lead to discrepant conclusions from cost-utility analyses.
- Knee osteoarthritis
- Knee pain
- Quality of life
The prevalence of knee osteoarthritis (OA) rapidly increases with age [1, 2]. Thus, it is expected that the number of people with knee OA will increase in the future due to the steadily aging population and increasing prevalence of obesity [3, 4]. The Global Burden of Disease (GBD) 2010 study ranked hip and knee OA as the 11th leading cause of years lived with disability (YLD) and the 38th highest contributor to disability-adjusted life years (DALYs) among 291 conditions . The share of total DALYs attributed to hip and knee OA increased from 0.49 % in 1990 to 0.69 % in 2010 (an estimated 64 % increase) .
OA is associated with substantial deteriorations in health-related quality of life (HRQoL) . A recent study in the UK ranked OA as the 3rd greatest contributor to loss of HRQoL among eleven long-standing health conditions . HRQoL constitutes a subjective and multidimensional concept that includes the physical, psychological, and social functioning related to a health condition or therapy . HRQoL can be used as a criterion to predict future health care consumption among people with OA . Therefore, measuring HRQoL is important not only to quantify the effects of disease and its treatments, but also to aid informed decision-making in allocation of often limited healthcare resources.
The relatively weak association between clinical symptoms of OA and radiographic evidence of the disease has contributed to the existence of several definitions of OA for study purposes. The multiple definitions represent a major challenge in studies on OA . A radiographic definition of OA (most commonly using Kellgrene-Lawrence scale  with the cut-off of grade 2 or worse) and the clinical definition proposed by the American College of Rheumatology (ACR)  are two most commonly used definitions in the literature. While the impact of knee pain and knee OA on HRQoL has been investigated in the literature [13–15], there is a lack of knowledge on the impact of different definitions of OA on HRQoL. If such differences exist, the different OA definitions used in health economic evaluations may potentially yield different results and conclusions. Thus, in the present study our main aim was to evaluate and compare the impact of these two definitions of knee OA on HRQoL. These were based on patient-reported knee pain, and/or radiographically evident knee OA, as well as clinically defined knee OA. We related our findings to knee-healthy reference participants drawn from the same source population.
Setting and participants
The Malmö OA study (MOA) originated from the Malmö Diet and Cancer Study (MDCS) cohort established between 1991 and 1996 . All men aged 45–73 years and women aged 44–74 years at the time of enrolment living in the city of Malmö were invited to participate in the MDCS (n = 74 138). A cohort of 28 098 had completed baseline examinations . In the year 2007 a postal questionnaire about knee pain was sent to a 10 000 random sample from the MDCS who completed the MDCS baseline examination and were still alive and resident in the Malmö area. Respondents answered a question about whether they had knee pain during the previous 12 months and its duration (<1 week, 1–4 weeks, 1–3 months, >3 months). In the second stage, a random sample of 1300 participants with pain in one or both knees in the past 12 months and duration of at least 4 weeks (group A) and 650 participants without knee pain or with knee pain for shorter duration (group B) were invited to a clinical visit and radiographic examination [16, 18]. Of these, 1028 (79 %) people from group A and 499 (77 %) people from group B participated and were included in the present study.
Radiographic evaluation and knee OA definitions
Both knees were radiographed in a weight-bearing and semi-flexed position (knees in 10–15° of flexion) using a posterior-anterior beam direction (film focus distance 110 cm, 60 kV and 10 mA) with the aid of fluoroscopy to optimally align the tibia plateau. An independent senior radiologist specialized in musculoskeletal conditions who was blinded to the clinical data assessed joint space narrowing and osteophytes according to the atlas from the Osteoarthritis Research Society International [16, 19]. We classified a knee as having radiographic knee OA if one or more of the following criteria were fulfilled in either the medial, lateral tibiofemoral compartment or patellofemoral compartment: joint space narrowing grade 2 or worse, the sum of marginal osteophyte grades in the same compartment 2 or worse, joint space narrowing grade 1 and osteophyte grade 1 in the same compartment (approximating Kellgren and Lawrence (KL) grade 2 or worse) .
All participants answered the 5 questions included in the ACR clinical criteria for knee OA. We classified a participant as having clinical OA if fulfilling ACR clinical criteria according to the recursive partitioning method . Five items are included in the ACR criteria (28): (a) knee pain for most days of the prior month, (b) crepitus on active joint motion, (c) morning stiffness of duration < 30 min, (d) age ≥ 38 years, and (e) bony enlargement of the knee on examination. Knee OA was present if items “a”, “b”, “c”, “d” or items “a”, “b”, “e” or items “a” and “e” were present . We used the ACR clinical criteria “a” (i.e. knee pain for most days of the prior month) to define knee pain in our study. It should be noted that as this definition was different from the definition of knee pain in the first stage and also due to gap between the first and second stages of the study, people who defined as having knee pain in the first stage could have been classified as not having knee pain and vice versa.
We classified participants into four exposure groups based on their clinical and radiographic knee status: 1) reference group having neither knee pain nor radiographic or clinically-defined knee OA (n = 744), 2) knee pain without OA, i.e., participants with knee pain but without radiographic or clinically-defined knee OA (n = 169), 3) knee pain with OA, i.e., participants with knee pain having either radiographic knee OA or clinically-defined knee OA (n = 402), and 4) radiographic knee OA but no knee pain, i.e. participants without knee pain but fulfilling the radiographic defined knee OA (n = 186). A total of 26 participants with missing value on knee OA status were excluded. Additionally, to assess the impact of different definition of knee OA on HRQoL, the participants with knee OA (i.e., groups 3 & 4) were collapsed, then classified into three subgroups: those fulfilling the criteria for a) radiographic knee OA (n = 282), b) clinical knee OA (n = 157), and c) both clinical and radiographic knee OA (n = 149).
Health-related quality of life measurement
The EQ-5D-3L is a generic multi-attribute instrument to elicit health-related preferences. The EQ-5D-3L covers five attributes: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each attribute has three levels: no problems, moderate problems, and severe problems, resulting in 243 (35) possible health states . The responses to these attributes are weighted based on the preferences elicited from a general population/patients sample to calculate an index score. We used the UK  and recently developed Swedish  sets of preferences to calculate the index score. The UK EQ-5D-3L scores range between −0.594 and 1 (full health), while the Swedish scores range between 0.340 and 0.969.
The Knee injury and Osteoarthritis Outcome Score (KOOS) is a validated knee specific instrument [24, 25]. The KOOS is a 42-item self-administered questionnaire covering 5 subscales: pain, other symptoms, function in daily living (ADL), function in sport and recreation (Sport/Rec) and knee related quality of life (QoL). All items have five possible answer options scored from 0 (no problems) to 4 (extreme problems). A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale. As our participants were an elderly population, we included a sixth answer option (not applicable) into the case report form for the subscale Sport/Rec. If the box “not applicable” was marked, the item was treated as missing data. Since a large number of participants selected this option, we decided not to include this subscale in our analysis.
Explanatory variables (confounders)
To avoid potential confounder bias, the following explanatory variables were included in our regression analysis: sex, age, body mass index (BMI), comorbidity, years of education, employment, and smoking. Age and BMI were included as continuous variables. Comorbidity was defined as presence of self-reported doctor’s diagnosis of one or more of the following comorbidities: back problems, other joint problems (except knees), asthma/lung disease, hypertension, heart disease, stroke, leg artery disease, neurological disease, diabetes, cancer, gastric ulcer, renal disease, anemia/blood disease, eye disease/visual impairment, balance disorder, depression, and other psychiatric disorder. Three groups were defined: no comorbidity, single comorbidity, and multiple comorbidities. Years of education were categorized in three groups: ≤9 years, 9–12 years, and >12 years. Employment was defined in three categories: employed, unemployed, and retired. We grouped smoking in three groups as: never, current smoker, and ex-smoker.
We applied weighting to account for a possible selection bias that might arise from non-responses in the first or second part in the MOA study . A logistic regression model with sex, age on 1 January 2007, education, smoking, and BMI as covariates was used to estimate the probability of response in the first stage of survey. Similar logistic regression models including knee pain during last 12 months as an additional covariate were applied to estimate the probability of participation and attendance at the clinical examination. The sampling weights (the reciprocal of the sampling probability for those with and without knee pain ≥ 4 weeks duration) were multiplied by the weights for response, participation and attendance to construct the final weights used in analyses.
We present continuous variables using means and standard deviations. The mean differences between groups were tested using one-way analysis of variance (ANOVA) and Bonferroni post-hoc tests. Proportions were compared using Pearson Chi-2 test. Adjusted analysis was conducted using Ordinary least squares regression with robust standard errors. Due to the skewed distribution of the EQ-5D-3L data, several different methods have been applied to these data in the literature [27, 28], but ordinary least squares (OLS) regression is considered as a simple and valid approach . The linearity of the continuous variables was checked using design variables and residual plots and non-linearity was modelled using fractional polynomial. The possible reasonable linear and non-linear interactions were also checked using the same approach . Potential confounders (age, sex, body mass index, comorbidity, years of education, employment, and smoking) were included in the models regardless of their significance level. STATA version 13 (StataCorp LP, College Station, TX, USA) was used for statistical analysis.
Characteristics of participants included in the Malmö osteoarthritis study (MOA)
Reference group (n = 744)
Knee pain without knee OA (n = 169)
Knee pain with knee OA (n = 402)
Radiographic knee OA without pain (n = 186)
Age, years (SD)
Years of education, %
≤ 9 years
> 9 years & ≤ 12 years
Percentage (95 % CI) of participants with moderate/severe problems in the EQ-5D-3L attributes, mean (95 % CI) EQ-5D-3L index and KOOS scores in the full sample
Reference group (n = 744)
Knee pain without knee OA (n = 169)
Knee pain with knee OA (n = 402)
Radiographic knee OA without knee pain (n = 186)
11.5 (8.9 to 14.8)
32.6 (23.1 to 43.8)a
52.2 (44.8 to 59.5)ab
34.7 (25.4 to 45.5)ac
0.2 (0.1 to 0.5)
2.7 (1.3 to 5.6)a
7.3 (3.5 to 14.5)a
3.6 (1.0 to 12.3)a
5.6 (3.9 to 8.0)
21.9 (14.3 to 32.0)a
24.8 (20.1 to 30.3)a
10.0 (5.1 to 18.7)bc
35.9 (31.8 to 40.3)
88.1 (76.1 to 94.5)a
96.7 (92.1 to 98.7)ab
70.4 (60.1 to 78.9)abc
17.5 (14.3 to 21.1)
30.2 (20.9 to 41.3)a
32.2 (25.9 to 39.4)a
21.4 (13.9 to 31.4)
No problem at any dimension (full health)
54.2 (50.0 to 58.6)
7.7 (2.9 to 19.0)a
3.1 (1.2 to 7.8)a
22.6 (15.2 to 32.2)abc
Mean UK EQ-5D-3L index score
0.89 (0.87 to 0.90)
0.71 (0.67 to 0.75)a
0.67 (0.64 to 0.69)ab
0.77 (0.72 to 0.82)abc
Mean Swedish EQ-5D-3L index score
0.93 (0.93 to 0.94)
0.87 (0.85 to 0.89)a
0.84 (0.83 to 0.85)ab
0.89 (0.87 to 0.91)abc
92.8 (91.8 to 93.8)
68.9 (64.3 to 73.4)a
55.4 (52.9 to 57.8)ab
81.4 (78.2 to 84.6)abc
66.1 (65.4 to 66.8)
56.7 (54.4 to 58.9)a
48.2 (46.5 to 50.0)ab
61.6 (59.5 to 63.8)abc
91.3 (90.1 to 92.6)
70.3 (65.6 to 74.9)a
56.2 (53.1 to 59.3)ab
80.1 (76.4 to 83.9)abc
86.4 (84.9 to 87.9)
56.9 (51.6 to 62.1)a
40.1 (37.4 to 42.9)ab
66.4 (61.9 to 70.8)abc
Percentage (95 % CI) of participants with moderate/severe problems in the EQ-5D-3L attributes, mean (95 % CI) EQ-5D-3L index and KOOS scores among participant with knee osteoarthritis (OA)
Radiographic knee OA (n = 282)
Clinical knee OA (n = 157)
Clinical and radiographic knee OA (n = 149)
40.5 (32.1 to 49.5)
38.9 (29.3 to 49.5)
59.7 (48.7 to 69.8)ab
5.5 (2.1 to 13.6)
5.0 (2.7 to 9.4)
5.3 (2.6 to 10.5)
12.2 (7.6 to 18.9)
27.4 (20.2 to 36.0)a
26.5 (19.3 to 35.2)a
76.3 (67.8 to 83.2)
98.6 (95.6 to 99.5)a
94.4 (82.2 to 98.4)a
23.4 (16.7 to 31.8)
36.0 (25.5 to 48.1)
29.7 (22.0 to 38.7)
No problem at any dimension (full health)
18.3 (12.4 to 26.1)
0.9 (0.2 to 3.5)a
5.6 (1.6 to 17.8)ab
Mean UK EQ-5D-3L index score
0.75 (0.71 to 0.79)
0.67 (0.63 to 0.71)a
0.66 (0.61 to 0.70)a
Mean Swedish EQ-5D-3L index score
0.88 (0.87 to 0.90)
0.84 (0.82 to 0.86)a
0.84 (0.81 to 0.86)a
75.6 (72.4 to 78.9)
58.6 (54.8 to 62.4)a
52.0 (47.5 to 56.6)ab
59.5 (57.6 to 61.4)
48.2 (45.6 to 50.7)a
45.0 (42.4 to 47.6)a
74.6 (70.8 to 78.4)
59.5 (54.4 to 64.6)a
53.6 (49.2 to 58.1)ab
60.5 (56.5 to 64.5)
44.2 (40.1 to 48.3)a
35.9 (30.3 to 41.5)ab
The effects of knee osteoarthritis (OA) on health-related quality of life: results from regression analysis
UK EQ-5D-3L index score
Swedish EQ-5D-3L index score
Knee pain without knee OA
Knee pain with knee OA
Radiographic knee OA without pain
Participants with knee OAa
Radiographic knee OA
Clinical knee OA
Clinical and radiographic knee OA
We measured and compared the impact of knee pain and knee OA on HRQoL, using both generic and disease-specific scales, in a large population-based cohort from southern Sweden. First, our results confirmed the expected notion that participants with either knee pain or knee OA (either clinically or radiographically defined) reported lower HRQoL scores than reference participants free of such knee pain and with no knee OA. We also found that knee pain without knee OA had more profound negative impact on HRQoL than radiographic knee OA without knee pain. Moreover, among participants with knee OA (either radiographically or clinically defined), those with clinical knee OA according to the ACR clinical definition reported lower scores of HRQoL than those who had radiographic knee OA not fulfilling the ACR clinical criteria.
The effect of different OA definitions in the study of prevalence and incidence of OA is well documented, where it was reported that radiographic definition of OA resulted in the highest prevalence estimates . The effect of different OA definitions on HRQoL is however much less well investigated, which may have important implications for the interpretation of findings from health economic evaluations. Our results suggest that the knee OA definition based on the ACR clinical criteria was associated with lower HRQoL than the definition based on radiographic knee OA. The presence of knee pain in the ACR clinical definition is a possible explanation for this finding. Interestingly, in our full sample, people with knee pain had lower HRQoL compared with people with radiographic features of knee OA without knee pain. In our sample, only 96 (22 %) of participants in the radiographic knee OA group experienced pain in most days during last month and interestingly the EQ-5D-3L index score for these 96 participants (0.66) was equal to participants in the clinical knee OA group (0.66).
Our finding of differences in HRQoL measures between persons fulfilling different definitions of knee OA (i.e., radiographic or clinical ACR criteria) has an important implication for cost-utility analyses. The difference in the mean HRQoL according to knee OA definition will result in different estimates of quality-adjusted life years (QALYs) which might yield discrepant and potentially conflicting conclusions from these analyses. For example, in our study, if a hypothetical intervention improved HRQoL of participants with knee OA to the level of the reference group (0.85), then QALYs gained from using clinical knee OA to define participants with knee OA (0.85 minus 0.66) would be 1.9 times higher than applying radiographic signs for definition of knee OA (0.85 minus 0.75). This translates into less favorable cost-effectiveness ratios using radiographic signs to define knee OA. This should be taken into account by policy makers when using cost-utility analysis to make decisions on funding of knee OA interventions.
In line with previous studies [31–33], we found that pain was the most affected dimension in the EQ-5D-3L questionnaires among participants with knee pain and knee OA. In our study the participants suffering from both knee pain and knee OA reported lower scores for all KOOS subscales compared to people with either knee pain or radiographic knee OA only. In addition, among participants with knee OA, radiographic knee OA without pain was associated with higher HRQoL than radiographic knee OA with pain. These findings suggest that the combination of knee pain and knee OA results in additional negative impact on HRQoL compared with knee pain or radiographic knee OA alone.
Mean EQ-5D-3L index score among participants with knee pain and knee OA in our study (0.65) was higher than people with knee OA in Singapore (0.49)  and UK (0.44)  using the UK weights. Differences in severity of knee OA, with a substantial portion of participants in those studies having severe disease and waiting for TKR might be an explanation. However, our EQ-5D-3L score is comparable to values reported among Swedish people waiting for total hip replacement (0.73)  and ACL surgery (0.69) . This similarity between Swedish patients with different severity highlights another potential explanation for higher scores among the Swedish patients than patients in other countries, i.e., clinical, environmental, organizational, and cultural differences between patients and countries in these studies.
The results of this study should be interpreted in light of some limitations. The MOA study originated from the MDCS whose participants were shown to have a slightly lower mortality than non-participants . Eleven percent of people with knee pain in the past 12 months and 30 % of participants without knee pain in past 12 month did not agree to participate in our study. If non-participation was associated with both knee pain/knee OA and HRQoL through unmeasured factors in our weighting exercise, then this is a potential source of selection bias and also could limit the generalizability of our findings. Another limitation of the current study is the self-reported nature of some explanatory variables (e.g., self-reported doctor-diagnosed comorbidity and smoking) that might be prone to recall bias or underreporting. The cross-sectional design of our study implies that any causal inference should be avoided.
The current study showed that participants with knee pain (with and without knee OA) have poorer HRQoL, measured by both generic and disease-specific scales, than the references. The presence of knee OA has additional negative impact on HRQoL above the knee pain alone. Importantly, we found that applying different definitions of knee OA resulted in different levels of HRQoL and this was mainly explained by the knee pain experience. These differences are important to take into account when assessing the impact of knee OA on HRQoL and interpreting the results of cost-utility analyses.
We would like to thank the Malmö Diet Cancer Study cohort steering committee and their data managers for their assistance with the data transfer, and Dr Inga Redlund-Johnell for scoring of the MOA radiographs.
This work was supported by Astra Zeneca, the Swedish Research Council, Crafoord Foundation, The King Gustaf V 80-year Birthday Fund, Kock Foundations, the Faculty of Medicine Lund University, Governmental Funding of Clinical Research within National Health Service (ALF) and Region Skåne. The funding sources had no influence on the study design, collection, analysis and interpretation of data, in the writing the manuscript, or in the decision to submit the manuscript for publication.
Availability of data and materials
The dataset supporting the conclusions of this article will not be available in a public repository because consent/approval was not obtained for the sharing of subject data from participants or the Regional Ethics Committee in Lund.
AAK participated in the design, analysis, and interpretation of results and drafting the manuscript. CJL, MGdV, SL and GE participated in conception of the study, acquisition of data, and revision of the manuscript for important intellectual content. AT and ME participated in acquisition of data, interpretation of results, and revision of the manuscript for important intellectual content. All authors approved the final manuscript.
MGdV is employed by AstraZeneca and is an owner of AstraZeneca shares as part of the bonus system. GE and CJL were formerly employed by AstraZeneca R&D. All other authors have declared no conflicts of interest.
Consent for publication
Ethics approval and consent for participation
The study was approved by the Regional Ethics Committee in Lund and informed consent for participation was obtained from all participants in accordance with the Declaration of Helsinki.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Felson DT. The epidemiology of knee osteoarthritis: results from the Framingham Osteoarthritis Study. Semin Arthritis Rheum. 1990;20:42–50.View ArticlePubMedGoogle Scholar
- Busija L, Bridgett L, Williams SR, Osborne RH, Buchbinder R, March L, et al. Osteoarthritis. Best Pract Res Clin Rheumatol. 2010;24:757–68.View ArticlePubMedGoogle Scholar
- Reijman M, Pols HA, Bergink AP, Hazes JM, Belo JN, Lievense AM, et al. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. Ann Rheum Dis. 2007;66:158–62.View ArticlePubMedGoogle Scholar
- Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26:355–69.View ArticlePubMedPubMed CentralGoogle Scholar
- Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:1323–30.View ArticlePubMedGoogle Scholar
- Farr Ii J, Miller LE, Block JE. Quality of life in patients with knee osteoarthritis: a commentary on nonsurgical and surgical treatments. Open Orthop J. 2013;7:619–23.View ArticlePubMedPubMed CentralGoogle Scholar
- Wu M, Brazier JE, Kearns B, Relton C, Smith C, Cooper CL. Examining the impact of 11 long-standing health conditions on health-related quality of life using the EQ-5D in a general population sample. Eur J Health Econ. 2014;16(2):141–51.View ArticlePubMedPubMed CentralGoogle Scholar
- Revicki DA. Health-related quality of life in the evaluation of medical therapy for chronic illness. J Fam Pract. 1989;29:377–80.PubMedGoogle Scholar
- Ethgen O, Kahler KH, Kong SX, Reginster JY, Wolfe F. The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis. J Rheumatol. 2002;29:1147–55.PubMedGoogle Scholar
- Pereira D, Peleteiro B, Araujo J, Branco J, Santos RA, Ramos E. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage. 2011;19:1270–85.View ArticlePubMedGoogle Scholar
- KELLGREN JH, LAWRENCE JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494–502.View ArticlePubMedPubMed CentralGoogle Scholar
- Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29:1039–49.View ArticlePubMedGoogle Scholar
- Hill CL, Parsons J, Taylor A, Leach G. Health related quality of life in a population sample with arthritis. J Rheumatol. 1999;26:2029–35.PubMedGoogle Scholar
- Picavet HS, Hoeymans N. Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study. Ann Rheum Dis. 2004;63:723–9.View ArticlePubMedGoogle Scholar
- Muraki S, Akune T, Oka H, En-yo Y, Yoshida M, Saika A, et al. Association of radiographic and symptomatic knee osteoarthritis with health-related quality of life in a population-based cohort study in Japan: the ROAD study. Osteoarthritis Cartilage. 2010;18:1227–34.View ArticlePubMedGoogle Scholar
- Turkiewicz A, Gerhardsson de Verdier M, Engstrom G, Nilsson PM, Mellstrom C, Lohmander LS, et al. Prevalence of knee pain and knee OA in southern Sweden and the proportion that seeks medical care. Rheumatology (Oxford). 2015;54:827–35.View ArticleGoogle Scholar
- Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, Lindstrom M, et al. The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev. 2001;10:489–99.View ArticlePubMedGoogle Scholar
- Kiadaliri AA, Gerhardsson de Verdier M, Turkiewicz A, Lohmander LS, Englund M. Socioeconomic inequalities in knee pain, knee osteoarthritis, and health-related quality of life: a population-based cohort study in southern Sweden. Scand J Rheumatol. 2016:1–9. DOI:10.1080/03009742.2016.1181203
- Altman RD, Hochberg M, Murphy Jr WA, Wolfe F, Lequesne M. Atlas of individual radiographic features in osteoarthritis. Osteoarthritis Cartilage. 1995;3(Suppl A):3–70.PubMedGoogle Scholar
- Englund M, Roos EM, Lohmander LS. Impact of type of meniscal tear on radiographic and symptomatic knee osteoarthritis: a sixteen-year followup of meniscectomy with matched controls. Arthritis Rheum. 2003;48:2178–87.View ArticlePubMedGoogle Scholar
- Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53–72.View ArticlePubMedGoogle Scholar
- Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095–108.View ArticlePubMedGoogle Scholar
- Burstrom K, Sun S, Gerdtham UG, Henriksson M, Johannesson M, Levin LA, et al. Swedish experience-based value sets for EQ-5D health states. Qual Life Res. 2014;23:431–42.View ArticlePubMedGoogle Scholar
- Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS)--development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998;28:88–96.View ArticlePubMedGoogle Scholar
- Roos EM, Roos HP, Ekdahl C, Lohmander LS. Knee injury and Osteoarthritis Outcome Score (KOOS)--validation of a Swedish version. Scand J Med Sci Sports. 1998;8:439–48.View ArticlePubMedGoogle Scholar
- Little RJ, Vartivarian S. On weighting the rates in non-response weights. Stat Med. 2003;22:1589–99.View ArticlePubMedGoogle Scholar
- Hernandez Alava M, Wailoo AJ, Ara R. Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values. Value Health. 2012;15:550–61.View ArticlePubMedGoogle Scholar
- Basu A, Manca A. Regression estimators for generic health-related quality of life and quality-adjusted life years. Med Decis Making. 2012;32:56–69.View ArticlePubMedGoogle Scholar
- Pullenayegum EM, Tarride JE, Xie F, Goeree R, Gerstein HC, O’Reilly D. Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate? Value Health. 2010;13:487–94.View ArticlePubMedGoogle Scholar
- Royston P, Sauerbrei W. Multivariable Model-Building: A pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables. UK: Wiley; 2008.View ArticleGoogle Scholar
- Xie F, Li SC, Luo N, Lo NN, Yeo SJ, Yang KY, et al. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement. Arthritis Rheum. 2007;57:1043–9.View ArticlePubMedGoogle Scholar
- Turner AP, Barlow JH, Heathcote-Elliott C. Long term health impact of playing professional football in the United Kingdom. Br J Sports Med. 2000;34:332–6.View ArticlePubMedPubMed CentralGoogle Scholar
- Krupic F, Garellick G, Gordon M, Karrholm J. Different patient-reported outcomes in immigrants and patients born in Sweden: 18,791 patients with 1 year follow-up in the Swedish Hip Arthroplasty Registry. Acta Orthop. 2014;85:221–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 2004;13:873–84.View ArticlePubMedGoogle Scholar
- Gordon M, Greene M, Frumento P, Rolfson O, Garellick G, Stark A. Age- and health-related quality of life after total hip replacement: decreasing gains in patients above 70 years of age. Acta Orthop. 2014;85:244–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Ageberg E, Forssblad M, Herbertsson P, Roos EM. Sex differences in patient-reported outcomes after anterior cruciate ligament reconstruction: data from the Swedish knee ligament register. Am J Sports Med. 2010;38:1334–42.View ArticlePubMedGoogle Scholar